PORTLAND, Ore., August 9, 2021 / PRNewswire / – Allied Market Research recently released a report titled, “Bioreactor market by type (glass, stainless steel and single use), use (laboratory scale production, pilot scale production and large scale production), scale (5L-20L, 20L-200L, 200L-1500L and at above 1500L) and type of control (manual and automated): global opportunity analysis and industry forecast, 2021-2030 “. According to the report, the global bioreactor industry represented $ 2.61 billion in 2020, and is expected to reach $ 7.32 billion by 2030, with a CAGR of 10.7% from 2021 to 2030.
Download a sample report from: https://www.alliedmarketresearch.com/request-sample/2699
Main determinants of market growth
Increasing technological developments for advanced bioreactors, advancing R&D activities for new biological and microbial applications, and increasing demand for single-use bioreactors are driving the growth of the global bioreactor market. However, the high cost of bioreactors is hampering the growth of the market. On the contrary, the development of biotechnology and pharmaceutical industry is expected to open lucrative opportunities for market players in the future.
- The Covid-19 pandemic has presented unprecedented challenges for both consumers and the global economy. Manufacturing facilities were temporarily closed to curb the spread of infection, hampering the supply chain and creating a shortage of raw materials and finished products.
- The pandemic has strained the healthcare system and increased the need for vaccines and monoclonal antibodies for the prevention of Covid-19 infection. This has increased the R&D in the cell culture medium that grows in the bioreactors.
Single-use segment dominated market growth
By type, the single-use segment held the largest share in 2020, accounting for over three-fifths of the global bioreactor market. Moreover, the segment is expected to post the highest CAGR of 11.2% during the forecast period, owing to the strong increase in demand for biologics and the initiatives taken by the government for the development of the pharmaceutical sector. .
Investigation of the short and long term impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/2699
The large-scale production segment that will post the highest CAGR until 2030
By use, the large-scale production segment is expected to register the highest CAGR of 11.5% during the forecast period, due to the advancement of R&D activities for vaccine development, increase in adoption of advanced bioreactors and increasing prevalence of chronic diseases. However, the pilot-scale production segment held the largest share in 2020, contributing more than two-fifths of the global bioreactor market, due to the development of the pharmaceutical and biotechnology industry and the increase in the number. clinical and preclinical trial studies.
North America held the largest share
By region, the market across North America held the largest share in 2020, accounting for more than a third of the market, due to the increasing prevalence of chronic diseases, the presence of key players in the manufacture of advanced bioreactors and the progress of R&D in biomedical research in the region. However, the global bioreactor market across Asia Pacific is expected to post the highest CAGR of 12.3% during the forecast period, due to the increase in the prevalence of chronic diseases, the increase in demand for new biologics and the boom in Pharmaceutical industry.
Major market players
- BBI-Biotech GmbH
- Danaher Company
- Bioengineering AG
- Eppendorf AG
- Merck KGAA
- Infors HT
- Solaris biotechnology solutions
- Sartorius SA
- Thermo Fisher Scientific, Inc.
Basic Avenue map | Access to the library | One year subscription |
Sign up for the Avenue subscription to access over 12,000 company profiles and over 2,000 niche market research reports at $ 699 per month, per seat. For one year, the customer must purchase a minimum package of 2 places.
Avenue Library Subscription | Request 14-day free trial before purchasing: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
We’ve also posted some syndicated market research in the same area that you might be interested in. Below is the title of the report for your reference, considering the impact of Covid-19 on this market, which will help you assess the aftermath of the pandemic on the short and long term growth trends of this market. Marlet.
Vaccines Market Size 2021, Growth, Major Industry Players Like Pfizer, Sanofi Aventis, CSL Limited, Novavax with 6.6% CAGR – 2027
DNA Sequencing Market to Reach $ 25.47 billion by 2025 with advancements in DNA sequencing technologies across the world
The size of the pharmaceutical packaging market is expected to grow at 144.23 billion dollars, by 2027; Increase in green packaging solutions and increase in product innovations drive growth
Healthcare IT market size is expected to reach $ 880.6 billion by 2030 with the adoption of mHealth and telehealth practices
Home medical equipment market to experience record revenues $ 56.45 billion by 2027, registration at 6.1% CAGR | RAM
Gene Therapy Market Size to Reap $ 6.21 billion and growing to 34.8% CAGR by 2026
Meeting the challenges of the electronic health records (EHR) market [2021-2028]
Allied Market Research (AMR) is a full-service market research and business consulting arm of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global businesses as well as medium and small businesses with unmatched quality of “market research reports” and “business intelligence solutions”. AMR has a focused vision to provide business information and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.
We have professional relationships with various companies, which helps us extract market data which helps us generate accurate research data tables and confirm the highest accuracy in our market forecast. CEO of Allied Market Research Pawan kumar is essential in inspiring and encouraging everyone associated with the business to maintain high quality data and to help customers in every way possible to be successful. Each of the data presented in the reports we publish is extracted through primary interviews with senior officials of the main companies in the field concerned. Our secondary data sourcing methodology includes in-depth online and offline research and discussions with industry-savvy professionals and analysts.
5933 NE Win Sivers Drive
# 205, Portland, OR 97220
United States/Canada (Free): + 1-800-792-5285, + 1-503-894-6022, + 1-503-446-1141
UK: + 44-845-528-1300
Hong Kong: + 852-301-84916
India (Pune): + 91-20-66346060
The Web: https://www.alliedmarketresearch.com
Follow us on LinkedIn: https://www.linkedin.com/company/allied-market-research
SOURCE Allied market research